© 2020 Marker Therapeutics, Inc.
…JACKSONVILLE, Florida, October 7, 2015 /PRNewswire/ –
TapImmune, Inc. (TPIV), a clinical-stage immunotherapy company specializing in the development of innovative peptide and gene-based immunotherapeutics and vaccines for the treatment of cancer & metastatic disease, will be featured as a presenting company at the Aegis Capital Corp. 2015 Growth Conference, at the Encore Wynn Hotel in Las Vegas, Nevada which takes place October 7-9, 2015.